Search research articles
Contact Us
Filters
Showing results (61-70 of 438) with videos related to
Page
of 44
Sort By:
Journal of Clinical Medicine
|
February 25, 2022
Frequency of Renal Function Parameter Abnormalities in Patients with Psoriatic Arthritis and Rheumatoid Arthritis: Real-World Evidence from Clinical Practice
Fabiola Atzeni, Pietro Muto, Javier Rodríguez-Carrio, et al.
Clinical and Experimental Rheumatology
|
May 19, 2026
Fibromyalgia and metabolic syndrome: prevalence, potential shared pathophysiological mechanisms and non-pharmacological treatment strategies
Alessandra Alciati, Francesca Cracò, Alessandra Burgio, et al.
Expert Opinion on Pharmacotherapy
|
March 22, 2023
Conventional, biological disease-modifying anti-rheumatic drugs and Janus kinase inhibitors and varicella zoster virus
Fabiola Atzeni, Francesco Gozza, Agostino Riva, et al.
Pharmacological Research
|
April 7, 2021
Behçet disease: From pathogenesis to novel therapeutic options
Javier Rodríguez-Carrio, Valeria Nucera, Ignazio Francesco Masala, et al.
Clinical and Experimental Rheumatology
|
September 28, 2010
Successful treatment of leg ulcers in Behçet's disease using adalimumab plus methotrexate after the failure of infliximab
Fabiola Atzeni, Pietro Leccese, Salvatore D'Angelo, et al.
Autoimmunity Reviews
|
September 15, 2007
Potential target of infliximab in autoimmune and inflammatory diseases
Fabiola Atzeni, Andrea Doria, Mario Carrabba, et al.
Biologics : Targets & Therapy
|
March 26, 2013
Factors correlated with improvement of endothelial dysfunction during rituximab therapy in patients with rheumatoid arthritis
Maurizio Benucci, Gianantonio Saviola, Mariangela Manfredi, et al.
Expert Review of Clinical Immunology
|
August 1, 2013
Lung involvement and drug-induced lung disease in patients with rheumatoid arthritis
Fabiola Atzeni, Luigi Boiardi, Salvatore Sallì, et al.
European Journal of Internal Medicine
|
March 22, 2023
C-reactive protein level association with future cardiovascular events assessed by different risk scores among rheumatoid arthritis patients
Gian Luca Erre, Elena Bartoloni, Ombretta Viapiana, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
June 20, 2020
Potential Role of Anti-interleukin (IL)-6 Drugs in the Treatment of COVID-19: Rationale, Clinical Evidence and Risks
Salvatore Crisafulli, Valentina Isgrò, Laura La Corte, et al.
Page
of 44
Search research articles
Search
Showing results (61-70 of 438) with videos related to
Sort By:
Page
of 44
Journal of Clinical Medicine
|
February 25, 2022
Frequency of Renal Function Parameter Abnormalities in Patients with Psoriatic Arthritis and Rheumatoid Arthritis: Real-World Evidence from Clinical Practice
Fabiola Atzeni, Pietro Muto, Javier Rodríguez-Carrio, et al.
Clinical and Experimental Rheumatology
|
May 19, 2026
Fibromyalgia and metabolic syndrome: prevalence, potential shared pathophysiological mechanisms and non-pharmacological treatment strategies
Alessandra Alciati, Francesca Cracò, Alessandra Burgio, et al.
Expert Opinion on Pharmacotherapy
|
March 22, 2023
Conventional, biological disease-modifying anti-rheumatic drugs and Janus kinase inhibitors and varicella zoster virus
Fabiola Atzeni, Francesco Gozza, Agostino Riva, et al.
Pharmacological Research
|
April 7, 2021
Behçet disease: From pathogenesis to novel therapeutic options
Javier Rodríguez-Carrio, Valeria Nucera, Ignazio Francesco Masala, et al.
Clinical and Experimental Rheumatology
|
September 28, 2010
Successful treatment of leg ulcers in Behçet's disease using adalimumab plus methotrexate after the failure of infliximab
Fabiola Atzeni, Pietro Leccese, Salvatore D'Angelo, et al.
Autoimmunity Reviews
|
September 15, 2007
Potential target of infliximab in autoimmune and inflammatory diseases
Fabiola Atzeni, Andrea Doria, Mario Carrabba, et al.
Biologics : Targets & Therapy
|
March 26, 2013
Factors correlated with improvement of endothelial dysfunction during rituximab therapy in patients with rheumatoid arthritis
Maurizio Benucci, Gianantonio Saviola, Mariangela Manfredi, et al.
Expert Review of Clinical Immunology
|
August 1, 2013
Lung involvement and drug-induced lung disease in patients with rheumatoid arthritis
Fabiola Atzeni, Luigi Boiardi, Salvatore Sallì, et al.
European Journal of Internal Medicine
|
March 22, 2023
C-reactive protein level association with future cardiovascular events assessed by different risk scores among rheumatoid arthritis patients
Gian Luca Erre, Elena Bartoloni, Ombretta Viapiana, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
June 20, 2020
Potential Role of Anti-interleukin (IL)-6 Drugs in the Treatment of COVID-19: Rationale, Clinical Evidence and Risks
Salvatore Crisafulli, Valentina Isgrò, Laura La Corte, et al.
Page
of 44